Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in patients with advanced ...
The Manila Times on MSN
UP chemists develop hybrid molecules that may halt metastasis
Diliman have synthesized a new class of hybrid molecules that may help limit the spread of cancer cells by targeting a key enzyme involved in tumor progression. The compounds, developed by Christian ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
OncoLens and The Jackson Laboratory Launch Program to Expand Molecular Tumor Boards to Community Oncology Centers ...
SHENZHEN -- Chinese researchers have developed an innovative "intratumoral vaccine" molecule that prevents cancer cells from ...
Scientists have uncovered how a vitamin A metabolite can suppress anti-cancer immunity. Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have uncovered new ...
Researchers at the University of California San Diego have now developed a groundbreaking “one-click” AI tool that could ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback